These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35873251)

  • 1. Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.
    Kiraga MK; Kuypers KPC; Uthaug MV; Ramaekers JG; Mason NL
    Front Psychiatry; 2022; 13():883869. PubMed ID: 35873251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being.
    Kiraga MK; Mason NL; Uthaug MV; van Oorsouw KIM; Toennes SW; Ramaekers JG; Kuypers KPC
    Front Pharmacol; 2021; 12():721537. PubMed ID: 34658861
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.
    Perkins D; Pagni BA; Sarris J; Barbosa PCR; Chenhall R
    Front Pharmacol; 2022; 13():884703. PubMed ID: 36386199
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.
    Smigielski L; Kometer M; Scheidegger M; Krähenmann R; Huber T; Vollenweider FX
    Sci Rep; 2019 Oct; 9(1):14914. PubMed ID: 31649304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).
    Dworatzyk K; Jansen T; Schmidt TT
    PLoS One; 2022; 17(3):e0264927. PubMed ID: 35294453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.
    Søndergaard A; Madsen MK; Ozenne B; Armand S; Knudsen GM; Fisher PM; Stenbæk DS
    Front Psychol; 2022; 13():948729. PubMed ID: 36275302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study.
    Hartong V; van Emmerik A
    J Psychoactive Drugs; 2023; 55(3):310-320. PubMed ID: 35694791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study.
    van Oorsouw K; Toennes SW; Ramaekers JG
    Psychopharmacology (Berl); 2022 Jun; 239(6):1839-1852. PubMed ID: 35072760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution.
    Uthaug MV; van Oorsouw K; Kuypers KPC; van Boxtel M; Broers NJ; Mason NL; Toennes SW; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2018 Oct; 235(10):2979-2989. PubMed ID: 30105399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.
    Nayak SM; Jackson H; Sepeda ND; Mathai DS; So S; Yaffe A; Zaki H; Brasher TJ; Lowe MX; Jolly DRP; Barrett FS; Griffiths RR; Strickland JC; Johnson MW; Jackson H; Garcia-Romeu A
    Front Psychiatry; 2023; 14():1199642. PubMed ID: 37795509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
    McCulloch DE; Madsen MK; Stenbæk DS; Kristiansen S; Ozenne B; Jensen PS; Knudsen GM; Fisher PM
    J Psychopharmacol; 2022 Jan; 36(1):74-84. PubMed ID: 34189985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects.
    Smigielski L; Scheidegger M; Kometer M; Vollenweider FX
    Neuroimage; 2019 Aug; 196():207-215. PubMed ID: 30965131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
    Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
    JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
    Roseman L; Nutt DJ; Carhart-Harris RL
    Front Pharmacol; 2017; 8():974. PubMed ID: 29387009
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.
    Kettner H; Rosas FE; Timmermann C; Kärtner L; Carhart-Harris RL; Roseman L
    Front Pharmacol; 2021; 12():623985. PubMed ID: 33995022
    [No Abstract]   [Full Text] [Related]  

  • 16. Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study.
    Haijen ECHM; Hurks PPM; Kuypers KPC
    Front Psychiatry; 2023; 14():1233585. PubMed ID: 37915796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
    Nygart VA; Pommerencke LM; Haijen E; Kettner H; Kaelen M; Mortensen EL; Nutt DJ; Carhart-Harris RL; Erritzoe D
    J Psychopharmacol; 2022 Aug; 36(8):932-942. PubMed ID: 35924888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.
    Lebedev AV; Lövdén M; Rosenthal G; Feilding A; Nutt DJ; Carhart-Harris RL
    Hum Brain Mapp; 2015 Aug; 36(8):3137-53. PubMed ID: 26010878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding.
    Madsen MK; Fisher PM; Stenbæk DS; Kristiansen S; Burmester D; Lehel S; Páleníček T; Kuchař M; Svarer C; Ozenne B; Knudsen GM
    Eur Neuropsychopharmacol; 2020 Apr; 33():71-80. PubMed ID: 32146028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.
    Simonsson O; Goldberg SB
    J Psychoactive Drugs; 2023; 55(1):11-18. PubMed ID: 35000559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.